Publications by authors named "Carla Maria Boquimpani"

Article Synopsis
  • - Chronic Myeloid Leukemia (CML) predominantly affects adults aged 50 to 55; in 2017, over 12,000 patients in Brazil received outpatient treatment approval for CML despite the lack of reimbursements for necessary monitoring tests like quantitative PCR.
  • - Effective monitoring through molecular response evaluation is vital for optimal CML patient care, enabling timely interventions and even possible treatment discontinuation for suitable cases.
  • - Expert recommendations emphasize the urgent need for funding and reimbursement for molecular testing in SUS, highlighting potential cost savings from reduced medication usage when patients are closely monitored.
View Article and Find Full Text PDF